江苏康为世纪生物科技股份有限公司关于首次公开发行前股票期权行权限售股上市流通的公告

Core Points - The company Jiangsu Kangwei Century Biotechnology Co., Ltd. is set to list 434,236 shares for trading on December 22, 2025, as part of its stock option incentive plan [2][4][11] - The shares being listed are part of the first exercise period of the 2021 stock option incentive plan, with a lock-up period of 36 months from the exercise date [5][7] - The total share capital of the company has increased from 93,161,111 shares at the time of its initial public offering to 112,493,716 shares currently, reflecting various capital increases and stock option exercises [6] Summary of Key Information - The total number of shares to be listed for trading is 434,236 [3][11] - The shares will be available for trading starting December 22, 2025 [4][11] - The shares are part of the stock option plan approved by the China Securities Regulatory Commission, which allowed the company to issue 23,290,278 shares during its IPO [4][5] - The company has undergone several changes in its total share capital since its IPO, including a capital increase through a bonus issue [6] - Shareholders of the newly listed shares have committed to a lock-up period of 36 months and will adhere to the same reduction regulations as the company's directors and senior management after the lock-up period [7][9]